Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events

BACKGROUND: Patients with multiple clinical risk factors are a complex group in whom both bleeding and recurrent ischaemic events often occur during treatment with dual/triple antithrombotic therapy after percutaneous coronary intervention. Decisions on optimal antithrombotic treatment in these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Olie, R. H., van der Meijden, P. E. J., Vries, M. J. A., Veenstra, L., van ‘t Hof, A. W. J., ten Berg, J. M., Henskens, Y. M. C., ten Cate, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455732/
https://www.ncbi.nlm.nih.gov/pubmed/34468944
http://dx.doi.org/10.1007/s12471-021-01606-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455732/
https://www.ncbi.nlm.nih.gov/pubmed/34468944
http://dx.doi.org/10.1007/s12471-021-01606-2

Ejemplares similares